Background: Mometasone furoate (MF) is a new strongly lipophilic steroid which has an anti-inflammatory effect as evaluated by in vivo and in vitro studies. Objective: The objective of the present study was to investigate the degree of inhibition of experimental allergic contact dermatitis induced by the treatment with ME Methods: The therapeutic effect was evaluated by an echographic method associated with image analysis, MF activity was compared to that of hydrocortisone acetate 0.5% (Cortaid Cream, Lachifarma), clobetasone butyrate 0.05% (Eumovate Cream, Glare) and clobetasol propionate 0.05% (Clobesol Cream, Glare), classified respectively as weak, moderately potent and very potent steroids. Results: The different corticosteroid formulations employed for inhibiting experimentally induced contact dermatitis reflect the expected rank order of efficacy, Conclusion: MF behaves like clobetasol butyrate ranking as a moderately potent corticosteroid.
Inhibition of elicitation of contact dermatitis in humans by mometasone furoate: evaluation by means of 20-MHz B scanning associated with image analysis / A. Di Nardo, G. Giusti; L., Mantovani; B., Bianchi; Seidenari, Stefania. - In: DERMATOLOGY. - ISSN 1018-8665. - STAMPA. - 195:(1997), pp. 137-141.
Inhibition of elicitation of contact dermatitis in humans by mometasone furoate: evaluation by means of 20-MHz B scanning associated with image analysis
SEIDENARI, Stefania
1997
Abstract
Background: Mometasone furoate (MF) is a new strongly lipophilic steroid which has an anti-inflammatory effect as evaluated by in vivo and in vitro studies. Objective: The objective of the present study was to investigate the degree of inhibition of experimental allergic contact dermatitis induced by the treatment with ME Methods: The therapeutic effect was evaluated by an echographic method associated with image analysis, MF activity was compared to that of hydrocortisone acetate 0.5% (Cortaid Cream, Lachifarma), clobetasone butyrate 0.05% (Eumovate Cream, Glare) and clobetasol propionate 0.05% (Clobesol Cream, Glare), classified respectively as weak, moderately potent and very potent steroids. Results: The different corticosteroid formulations employed for inhibiting experimentally induced contact dermatitis reflect the expected rank order of efficacy, Conclusion: MF behaves like clobetasol butyrate ranking as a moderately potent corticosteroid.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
